Research from Water Tower Research, Water Tower Research

Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Research from Water Tower Research

Equity Research Firm

Equity Bottom-Up

<ul><li>On the latest WTR Healthcare Happenings podcast, we were joined by CEO Michael Heltzen of eXoZymes, Inc. (NASDAQ: EXOZ), a pioneering AIenhanced enzymes company that converts sustainable feedstocks into highvalue nutraceuticals and novel medicines.</li><li>The company has developed a next-generation biomanufacturing platform that is designed to efficiently produce valuable natural products and is currently advancing two flagship products: (1) an NCT (a rare natural compound that activates the cell’s master metabolic regulator) program</li><li>(2) a cannabinoid biomanufacturing platform.</li></ul>

On the latest WTR Healthcare Happenings podcast, we were joined by CEO Michael Heltzen of eXoZymes, Inc. (NASDAQ: EXOZ), a pioneering AIenhanced enzymes company that converts sustainable feedstocks into highvalue nutraceuticals and novel medicines.The company has developed a next-generation biomanufacturing platform that is designed to efficiently produce valuable natural products and is currently advancing two flagship products: (1) an NCT (a rare natural compound that activates the cell’s master metabolic regulator) program(2) a cannabinoid biomanufacturing platform.

WTR Healthcare Happenings Podcast Recap : EXoZymes